Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

被引：0
作者：
Eiichi Ogawa
Makoto Nakamuta
Toshimasa Koyanagi
Aritsune Ooho
Norihiro Furusyo
Eiji Kajiwara
Kazufumi Dohmen
Akira Kawano
Takeaki Satoh
Kazuhiro Takahashi
Koichi Azuma
Nobuyuki Yamashita
Naoki Yamashita
Rie Sugimoto
Hiromasa Amagase
Masami Kuniyoshi
Yasunori Ichiki
Chie Morita
Masaki Kato
Shinji Shimoda
Hideyuki Nomura
Jun Hayashi
机构：
[1] Kyushu University Hospital,Department of General Internal Medicine
[2] National Hospital Organization,Department of Gastroenterology, Kyushu Medical Center
[3] Fukuoka City Hospital,Department of Medicine
[4] Steel Memorial Yawata Hospital,Department of Hepatology
[5] Taihaku Avenue Clinic,General Internal Medicine
[6] Kajiwara Clinic,Department of Internal Medicine
[7] Chihaya Hospital,Department of Medicine
[8] Kitakyushu Municipal Medical Center,Center for Liver Disease
[9] Kokura Medical Center,Department of Medicine
[10] National Hospital Organization,Department of Medicine
[11] Hamanomachi Hospital,The Center for Liver Disease
[12] Kyushu Central Hospital,Department of Gastroenterology
[13] Shin-Kokura Hospital,Department of Gastroenterology
[14] Kyushu Cancer Center,Department of Internal Medicine
[15] Amagase Clinic,Department of Internal Medicine
[16] Kyushu Rosai Hospital,Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences
[17] JCHO Kyushu Hospital,Graduate School of Nutritional Sciences
[18] Kyushu Railway Memorial Hospital,Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences
[19] Kyushu University,Department of Internal Medicine
[20] Nakamura Gakuen University,Kyushu General Internal Medicine Center
[21] Kyushu University,undefined
[22] Haradoi Hospital,undefined
[23] Haradoi Hospital,undefined
来源：
Hepatology International | 2022年 / 16卷
关键词：
Hepatitis B virus; Tenofovir alafenamide; Entecavir; Tenofovir disoproxil fumarate; Sequential therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 293
页数：11
相关论文
共 196 条
  • [11] Ott JJ(2018)Chronic hepatitis B infection: a review JAMA 319 1802-1813
  • [12] Terrault NA(2016)Renal and bone toxicity with the use of tenofovir: understanding at the end AIDS Rev 18 59-68
  • [13] Lok ASF(2015)Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection Dig Dis Sci 60 1457-1464
  • [14] McMahon BJ(2016)Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Lancet Gastroenterol Hepatol 1 185-195
  • [15] Chang KM(2016)Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Lancet Gastroenterol Hepatol 1 196-206
  • [16] Hwang JP(2018)96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection J Hepatol 68 672-681
  • [17] Jonas MM(2020)Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B Liver Int 40 1578-1589
  • [18] Sarin SK(2009)Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982-992
  • [19] Kumar M(2011)Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog Hepatol Res 41 1178-1188
  • [20] Lau GK(2020)Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate J Med Virol 92 329-338
12345678910